Leadership Overview
Intas has 10 executives leading key functions including strategy, finance, operations, global markets, and legal.
Driven by innovation, Intas is dedicated to the manufacturing and research of pharmaceuticals, impacting global health through its extensive product portfolio and commitment to quality.
Driven by innovation, Intas is dedicated to the manufacturing and research of pharmaceuticals, impacting global health through its extensive product portfolio and commitment to quality.
Leadership Roles at Intas
Rathi Jeetesh - Chief Executive Officer
Rathi Jeetesh, the Chief Executive Officer at Intas, directs the company's overall strategic vision and operational execution. This leadership role involves guiding Intas's global expansion and ensuring alignment with its core mission of pharmaceutical manufacturing and research. Jeetesh oversees all major business units, fostering innovation and driving growth across diverse markets. The Chief Executive Officer's responsibilities include setting long-term objectives, managing key stakeholder relationships, and championing the company's commitment to quality and accessibility in healthcare. Rathi Jeetesh's strategic direction ensures Intas maintains its competitive edge in the pharmaceutical industry, focusing on developing and delivering essential medicines worldwide. This executive's influence extends to shaping corporate culture and driving operational excellence across all departments, solidifying Intas's position as a leader in pharmaceutical innovation and production.
Shivankur Mittal - Chief of Staff To Global Chief Executive Officer
Shivankur Mittal, the Chief of Staff To Global Chief Executive Officer at Intas, provides strategic support and operational coordination for the CEO's initiatives. This role involves managing key projects, facilitating communication across departments, and ensuring the effective execution of the CEO's strategic priorities in pharmaceutical manufacturing and research. Mittal acts as a key liaison, bridging executive leadership with operational teams to drive alignment and efficiency. The Chief of Staff's responsibilities include preparing executive briefings, analyzing business performance, and identifying areas for strategic intervention. Shivankur Mittal's support is crucial for the Global Chief Executive Officer in navigating complex business challenges and advancing Intas's mission. This executive's role ensures seamless operational flow and strategic focus at the highest levels of the organization.
Kshitiz Gadodia - Chief Financial Officer
Kshitiz Gadodia, the Chief Financial Officer at Intas, manages the company's financial health and strategic fiscal planning. This critical role involves overseeing all financial operations, including budgeting, forecasting, and capital allocation to support Intas's pharmaceutical manufacturing and research initiatives. Gadodia ensures robust financial controls and compliance, safeguarding the company's assets and optimizing profitability. The Chief Financial Officer's responsibilities extend to evaluating investment opportunities, managing investor relations, and driving financial strategies that align with Intas's global growth objectives. Kshitiz Gadodia's expertise is vital in navigating complex financial markets and ensuring sustainable economic performance for the organization. This executive's leadership in finance underpins the company's ability to fund research and development, expand manufacturing capabilities, and maintain a strong market presence.
Abhimanyu Ojha - Global Chief Financial Officer & Global President, Finance
Abhimanyu Ojha, the Global Chief Financial Officer & Global President, Finance at Intas, leads the company's comprehensive financial strategy and global fiscal operations. This dual role encompasses overseeing all financial planning, accounting, treasury, and investment activities to support Intas's extensive pharmaceutical manufacturing and research endeavors. Ojha is responsible for financial reporting, risk management, and ensuring compliance with international financial regulations. The Global Chief Financial Officer & Global President, Finance's mandate includes driving financial performance, optimizing capital structure, and supporting strategic mergers and acquisitions. Abhimanyu Ojha's leadership ensures financial stability and facilitates the company's global expansion and innovation pipeline. This executive's financial acumen is fundamental to Intas's sustained growth and market leadership.
Kirti Maheshwari - Chief Operating Officer
Kirti Maheshwari, the Chief Operating Officer at Intas, directs the company's day-to-day operational activities and process optimization. This role is central to ensuring the efficient manufacturing and research of pharmaceuticals, overseeing supply chain management, production schedules, and quality control systems. Maheshwari focuses on enhancing operational efficiency, reducing costs, and improving productivity across all manufacturing facilities. The Chief Operating Officer's responsibilities include implementing best practices in operational management and driving continuous improvement initiatives. Kirti Maheshwari's leadership ensures that Intas consistently delivers high-quality pharmaceutical products while meeting market demands. This executive's focus on operational excellence supports the company's mission to provide accessible healthcare solutions globally through effective and streamlined production processes.

Giridhar Venugopal - President, Emerging Markets & Bd
Giridhar Venugopal, the President, Emerging Markets & Bd at Intas, leads the company's strategic expansion and business development initiatives across key emerging markets. This role focuses on identifying new growth opportunities, establishing market presence, and driving revenue generation in diverse international regions for Intas's pharmaceutical products. Venugopal oversees market entry strategies, partnership development, and the adaptation of product portfolios to meet local healthcare needs. The President, Emerging Markets & Bd's responsibilities include managing regional teams, navigating regulatory landscapes, and ensuring the successful commercialization of Intas's offerings. Giridhar Venugopal's leadership is instrumental in expanding Intas's global footprint and reinforcing its commitment to making healthcare accessible worldwide through targeted market penetration.
Vijay Teng - Global President, Animal Health & Fertility
Vijay Teng, the Global President, Animal Health & Fertility at Intas, directs the strategic growth and operational management of the company's animal health and fertility product divisions. This specialized leadership role involves overseeing product development, market penetration, and sales strategies for these critical therapeutic areas. Teng is responsible for ensuring that Intas's offerings in animal health and fertility meet the highest standards of efficacy and safety, catering to global veterinary and reproductive health needs. The Global President's mandate includes fostering innovation, managing key partnerships, and driving commercial success within these specific market segments. Vijay Teng's expertise is crucial for advancing Intas's mission to provide comprehensive healthcare solutions across both human and animal health sectors.

C. Yagnik - President, Legal
C. Yagnik, the President, Legal at Intas, oversees all legal affairs and compliance matters for the organization. This critical function ensures that Intas operates within the bounds of national and international laws and regulations governing pharmaceutical manufacturing and research. Yagnik provides strategic legal counsel on corporate governance, intellectual property, contracts, and litigation, safeguarding the company's interests. The President, Legal's responsibilities include managing the legal department, advising executive leadership on risk mitigation, and ensuring adherence to ethical business practices. C. Yagnik's expertise is vital in navigating the complex legal landscape of the pharmaceutical industry, supporting Intas's global operations and commitment to integrity and compliance.
Anshu Verma - Senior General Manager, External Manufacturing (Chief Marketing Officer and CDMO)
Anshu Verma, the Senior General Manager, External Manufacturing (Chief Marketing Officer and CDMO) at Intas, spearheads the company's external manufacturing partnerships and contract development and manufacturing organization (CDMO) services. This multifaceted role involves managing relationships with external manufacturing partners, ensuring adherence to Intas's stringent quality standards in pharmaceutical production. Verma also drives the marketing and business development efforts for CDMO services, attracting new clients and expanding Intas's market reach in contract manufacturing. The Senior General Manager's responsibilities include overseeing project timelines, managing client expectations, and ensuring the successful delivery of outsourced manufacturing solutions. Anshu Verma's strategic oversight is critical for optimizing external production capabilities and enhancing Intas's position as a leading CDMO provider in the pharmaceutical sector.
Shivam Mittal - Executive Vice President & Global Chief Information Officer
Shivam Mittal, the Executive Vice President & Global Chief Information Officer at Intas, directs the company's global information technology strategy and infrastructure. This pivotal role involves overseeing all aspects of IT operations, including digital transformation initiatives, cybersecurity, and the implementation of advanced technological solutions to support pharmaceutical manufacturing and research. Mittal ensures that Intas's IT systems are robust, secure, and scalable, enabling efficient data management and operational continuity. The Executive Vice President & Global Chief Information Officer's responsibilities include developing IT policies, managing technology investments, and fostering innovation through digital advancements. Shivam Mittal's leadership is essential for leveraging technology to enhance productivity, streamline processes, and maintain Intas's competitive advantage in the global pharmaceutical landscape.
Explore Leadership Teams in Manufacturing
Sandoz Group AG (SIX: SDZ) is a global healthcare company focused on developing, manufacturing, and delivering high-quality generic medicines and biosimilars. Serving patients worldwide, Sandoz provides treatments across multiple therapeutic areas, including oncology, immunology, and cardiovascular health.
Company Leadership AJ
SA
MN
MH
Sanofi is a global biopharmaceutical company dedicated to improving lives through scientific innovation. The company focuses on discovering, developing, and delivering medicines and vaccines across immunology, rare diseases, neurology, oncology, and preventive care. Guided by research and patient needs, it works with healthcare partners worldwide to advance sustainable and responsible healthcare solutions.
Company Leadership AH
EH
JB
DS
Dexcel Pharma is Israel’s largest privately owned pharmaceutical company, founded in 1968 and headquartered in Or Akiva. It develops, manufactures, and commercializes value‑added branded prescription drugs, generics, and OTC products—primarily oral solid dosage forms—supplying more than 85 products in over 175 dosage forms to markets including the U.S., U.K., Germany, Austria, and others through subsidiaries and distribution partners.
Company Leadership
UE
EH

Revolution Medicines Inc is a pioneering biotechnology company committed to revolutionizing treatment for patients battling cancer. They are driven by a singular mission: the discovery, development, and delivery of innovative, targeted medicines, particularly focusing on what are known as RAS-addicted cancers, which represent a significant proportion of new human cancer diagnoses. The company has developed a groundbreaking tri-complex inhibitor platform to create a portfolio of RAS(ON) inhibitors, enabling a differentiated approach to target what was previously considered an undruggable molecular target in oncology. Through their tireless efforts and commitment to transformative science, they are building a deep pipeline of therapeutic candidates intended to change the standard of care for patients with these challenging diseases.
Company Leadership AS

SK